Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) (Q66409609)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) |
clinical trial |
Statements
A Phase I/II Study of Pembrolizumab and Vorinostat in Patients With Immune Therapy Naïve and Immune Therapy Pretreated Stage IV NSCLC (English)
0 references
24 February 2016
0 references
November 2019
0 references
100
0 references
18 year
0 references